Hydrocortisone and Fludrocortisone for the Treatment of Septic Shock
ConditionSeptic Shock
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18-90
SponsorNorthern Jiangsu People's Hospital
About this trial
The purpose of this study is to evaluate the efficacy and safety of the combination therapy of hydrocortisone and fludrocortisone among adult patients with septic shock.
Eligibility criteria
Qualifiers
None
Disqualifiers
Systemic corticosteroid therapy within the last 3 months before septic shock;
High-dose steroid therapy;
Immunosuppression;
Pregnant;
Trial design
Treatments tested in this trial
- Hydrocortisone plus Fludrocortisone
- Standard care
Treatment groups
336 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov